A groundbreaking review titled Medical Cannabis & Epilepsy has been released by Maple Tree Consultants, providing a comprehensive analysis of the role of cannabis-based medicines in managing epilepsy. This publication, co-authored by experts including Professor Mike Barnes and Hannah Deacon, compiles findings from nearly 100 clinical trials and observational studies, making it an invaluable resource for healthcare professionals and regulators.

The review delves into how cannabinoids can modulate brain pathways to reduce seizures, particularly in drug-resistant epilepsy cases. It also addresses the challenges patients face in accessing these treatments within the UK’s regulatory framework, emphasizing the reliance on private clinics due to limited NHS access. Co-author Hannah Deacon highlights the transformative impact of medical cannabis on her son Alfie’s life, underscoring the publication’s potential to enhance treatment accessibility and support for affected families.

For more details, visit Cannabis Health News.